aesvcast

Property	Value
?:abstract	SUMMARY The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2 The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29% In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality RESUMO Infecção pelo COVID-19 (SARS-CoV-2) começou na China, cidade de Wuhan, província de Hubei, em dezembro de 2019, e foi declarada pandemia em meados de março de 2020, causada por uma nova cepa de coronavírus chamada SARS-CoV-2 A patogênese da lesão renal atribuída à SARS-CoV-2 ainda não está bem definida Observações mostram que o dano renal causado pela nova mutação viral é principalmente tubular, com comprometimento da filtração glomerular e apresentação de altos níveis de uréia e creatinina Estudo com pacientes gravemente enfermos com COVID-19 mostrou que a lesão renal aguda estava presente em 29% Diante dessas evidências, com base em estudos recentes, podemos ver a grande contribuição renal como um fator de impacto na evolução do COVID-19, não apenas como um complicador da gravidade, mas talvez como parte da cascata inicial do processo, exigindo uma investigação de análise mais profunda usando biomarcadores convencionais de lesão renal e intervenção clínica mais agressiva em pacientes em risco, na tentativa de reduzir a mortalidade The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2. The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet. Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine. A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29%. In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/aesvcast_hasAnnotation_C0042776> <https://research.tib.eu/covid-19/entity/aesvcast_hasAnnotation_C0231218> <https://research.tib.eu/covid-19/entity/aesvcast_hasAnnotation_C1825598> <https://research.tib.eu/covid-19/entity/aesvcast_hasAnnotation_C2985439> <https://research.tib.eu/covid-19/entity/aesvcast_hasAnnotation_C5203676>
?:creator	<https://research.tib.eu/covid-19/entity/Duarte%2C_Pastora_Maria_de_Ara%C3%BAjo%3B_Bastos_Filho%2C_Francisco_Andr%C3%A9_Gomes%3B_Duarte%2C_Jo%C3%A3o_Vitor_Araujo%3B_Duarte%2C_Beatrice_Ara%C3%BAjo%3B_Duarte%2C_Isabella_Araujo%3B_Lemes%2C_Rom%C3%A9lia_Pinheiro_Gon%C3%A7alves%3B_Duarte%2C_Fernando_Barroso> <https://research.tib.eu/covid-19/entity/Duarte%2C_Pastora_Maria_de_Ara%C3%BAjo_Bastos_Filho_Francisco_Andr%C3%A9_Gomes_Duarte_Jo%C3%A3o_Vitor_Araujo_Duarte_Beatrice_Ara%C3%BAjo_Duarte_Isabella_Araujo_Lemes_Rom%C3%A9lia_Pinheiro_Gon%C3%A7alves_Duarte_Fernando_Barroso>
?:journal	Rev._Assoc._Med._Bras._(1992) Rev_Assoc_Med_Bras_(1992)
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	WHO
?:title	Renal changes in COVID-19 infection
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#742314 #918987
?:year	2020

Property

Value

?:abstract

SUMMARY The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2 The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29% In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality RESUMO Infecção pelo COVID-19 (SARS-CoV-2) começou na China, cidade de Wuhan, província de Hubei, em dezembro de 2019, e foi declarada pandemia em meados de março de 2020, causada por uma nova cepa de coronavírus chamada SARS-CoV-2 A patogênese da lesão renal atribuída à SARS-CoV-2 ainda não está bem definida Observações mostram que o dano renal causado pela nova mutação viral é principalmente tubular, com comprometimento da filtração glomerular e apresentação de altos níveis de uréia e creatinina Estudo com pacientes gravemente enfermos com COVID-19 mostrou que a lesão renal aguda estava presente em 29% Diante dessas evidências, com base em estudos recentes, podemos ver a grande contribuição renal como um fator de impacto na evolução do COVID-19, não apenas como um complicador da gravidade, mas talvez como parte da cascata inicial do processo, exigindo uma investigação de análise mais profunda usando biomarcadores convencionais de lesão renal e intervenção clínica mais agressiva em pacientes em risco, na tentativa de reduzir a mortalidade
The COVID-19 (SARS-CoV-2) infection started in China, Wuhan City, Hubei Province, in December 2019, and it was declared a pandemic in mid-March 2020, caused by a new coronavirus strain called SARS-CoV-2. The pathogenesis of kidney injury attributed to SARS- CoV-2 is not well defined yet. Observations show that the kidney damage caused by the new virus mutation is mainly tubular, with impairment of glomerular filtration and high levels of urea and creatinine. A study with seriously ill patients with COVID-19 showed that acute kidney injury was present in 29%. In the face of this evidence, based on recent studies, we can see the great renal contribution as an impact factor in the evolution of COVID-19, not just as a complicator of severity, but maybe part of the initial cascade of the process, requiring a deeper analysis using conventional biomarkers of kidney injury and more aggressive clinical intervention in patients at risk, in an attempt to reduce mortality.

is ?:annotates of